Cordyceps Sunshine Biotech Holdings (RAJAF) Other Accumulated Expenses (2022 - 2025)

Cordyceps Sunshine Biotech Holdings' Other Accumulated Expenses history runs 3 years deep, the most recent figure standing at $7892.0 for Q4 2025.

• In Q4 2025, Other Accumulated Expenses rose 51.01% year-over-year to $7892.0; the TTM figure through Dec 2025 stood at $7892.0 (up 51.01% YoY), while the FY2025 annual figure was $7892.0, up 51.01% from the prior year.
• Other Accumulated Expenses was $7892.0 for Q4 2025 at Cordyceps Sunshine Biotech Holdings, up from $5226.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $1.4 million in Q4 2022 to a low of $5226.0 in Q4 2024.
• Historically, Other Accumulated Expenses has averaged $463798.3 across 3 years, with a median of $7892.0 in 2025.
• Biggest YoY gain for Other Accumulated Expenses was 51.01% in 2025; the steepest drop was 51.01% in 2025.
• A 3-year view of Other Accumulated Expenses shows it stood at $1.4 million in 2022, then sank by 99.62% to $5226.0 in 2024, then soared by 51.01% to $7892.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $7892.0 (Q4 2025), $5226.0 (Q4 2024), and $1.4 million (Q4 2022), per Business Quant data.